Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 25;10(41):4083-4090.
doi: 10.18632/oncotarget.26937.

Palmitate up-regulates laminin expression via ROS/integrin αvβ3 pathway in HLSECs

Affiliations

Palmitate up-regulates laminin expression via ROS/integrin αvβ3 pathway in HLSECs

Qi Zhang et al. Oncotarget. .

Abstract

Aims/introduction: To investigate the roles of reactive oxygen species (ROS) and integrin αvβ3 in palmitate-induced laminin expression of human liver sinusoidal endothelial cells (HLSECs).

Results: The protein expression of integrin αv, integrin β3 and laminin are increased by palmitate in HLSECs in a time- and dose-dependent manner. NAC, the ROS inhibitor, significantly inhibited the up-regulation of protein expression of integrin αv, integrin β3 and laminin by palmitate (P < 0.05). Palmitate markedly enhanced ROS formation (P < 0.05), which was not inhibited by LM609, the antibody of integrin αvβ3. Palmitate significantly increased laminin synthesis (P < 0.05), which was attenuated by LM609 and NAC (P < 0.05).

Materials and methods: HLSECs were treated with palmitate in the presence or absence of LM609 (10 μg/ml) or N-acetylcysteine (NAC) (2 mM). Expression of integrin αv, integrin β3 and laminin were measured by RT-PCR and Western blot. Immunocytochemistry were used for examining laminin expression. The generation of ROS was measured using the fluorescent signal 2',7' dichloro-fluorescein diacetate (DCFH-DA).

Conclusions: The results suggested that palmitate increases laminin expression through ROS/integrin αv/β3 pathway.

Keywords: human liver sinusoidal endothelial cells; integrin αvβ3; laminin.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1. Palmitate induced ROS formation and the mRNA expression integrin αv, integrin β3 and laminin in HLSECs.
Cells were cultured with BSA and palmitate 50 umol/L, 100 umol/L 200 umol/L for 6, 24 and 48 h respectively. (A) Statistical data of ROS expression by the fluorescent signal DCFH-DA. (B) Statistical data of integrin αv mRNA expression by Quantitative RT-PCR. (C) Statistical data of integrin β3 mRNA expression by Quantitative RT-PCR. (D) Statistical data of laminin mRNA expression by Quantitative RT-PCR Data are expressed as mean ± S.D. from three independent experiments, *P < 0.05 vs control (BSA).
Figure 2
Figure 2. Palmitate increased the protein expression of integrin αv and integrin β3 in HLSECs.
(A) Representative photograph of Western blot. (B) Statistical data of integrin αv expression. (C) Statistical data of integrin β3 expression. Results are expressed as mean ± S.D. from three independent experiments, *P < 0.05 vs control (BSA).
Figure 3
Figure 3. Effect of NAC (2 mM, 24 h) on integrin αv and integrin β3 expression.
Cells were treated with 100 μmol/L palmitate for 48 h. (A) Representative photograph of Western blot. (B) Statistical data of integrin αv expression. (C) Statistical data of integrin β3 expression. Results are expressed as mean ± S.D. from three independent experiments, *P < 0.05 vs control (BSA), **P < 0.05 vs palmitate.
Figure 4
Figure 4. Palmitate induced ROS formation and effect of LM609 (10 μg/ml, 12 h) on ROS expression in HLSECs.
Cells were treated with 100 μmol/L palmitate for 48 h. Results are expressed as mean ± S.D. from three independent experiments, *P < 0.05 vs control (BSA).
Figure 5
Figure 5. Effect of palmitate, NAC and LM609 on protein expression of laminin in HLSCEs.
Cells were treated with 100 μmol/L palmitate for 48 h. (A) Representative photograph of Immunocytochemistry. (B) Statistical data of laminin expression. Results are expressed as mean ± S.D. from three independent experiments, *P < 0.05 vs control (BSA), **P < 0.05 vs palmitate.
Figure 6
Figure 6. Effect of palmitate, NAC and LM609 on protein expression of laminin in HLSCEs.
Cells were treated with 100 μmol/L palmitate for 48 h. (A) Representative photograph of Western-Blot. (B) Statistical data of laminin expression. Results are expressed as mean ± S.D. from three independent experiments, *P < 0.05 vs control (BSA), **P < 0.05 vs palmitate.

Similar articles

Cited by

  • Role of liver sinusoidal endothelial cells in liver diseases.
    Gracia-Sancho J, Caparrós E, Fernández-Iglesias A, Francés R. Gracia-Sancho J, et al. Nat Rev Gastroenterol Hepatol. 2021 Jun;18(6):411-431. doi: 10.1038/s41575-020-00411-3. Epub 2021 Feb 15. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33589830 Review.

References

    1. de Alwis NM, Day CP. Non-alcoholic fatty liver disease: The mist gradually clears. Journal of Hepatology. 2008; 48:S104–S112. 10.1016/j.jhep.2008.01.009. - DOI - PubMed
    1. Rösen P, Nawroth PP, King G, Möller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev. 2001; 17:189–212. 10.1002/dmrr.196. - DOI - PubMed
    1. Pérez FR, Piñeiro V, De La Cruz LF, Casanueva FF, Casabiell X. Vascular wall: potential target for the physicochemical effects of cis-unsaturated free fatty acids. Microsc Res Tech. 2003; 60:23–29. 10.1002/jemt.10239. - DOI - PubMed
    1. Castro Cabezas M, Erkelens DW, Van Dijk H. [Free fatty acids: mediators of insulin resistance and atherosclerosis]. [Article in Dutch]. Ned Tijdschr Geneeskd. 2002; 146:103–109. - PubMed
    1. Braet F, Wisse E. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp Hepatol. 2002; 1:1. 10.1186/1476-5926-1-1. - DOI - PMC - PubMed

LinkOut - more resources